141 related articles for article (PubMed ID: 21904434)
1. Molecular modeling of human neutral sphingomyelinase provides insight into its molecular interactions.
Dinesh ; Goswami A; Suresh PS; Thirunavukkarasu C; Weiergräber OH; Kumar MS
Bioinformation; 2011; 7(1):21-8. PubMed ID: 21904434
[TBL] [Abstract][Full Text] [Related]
2. Distinct adapter proteins mediate acid versus neutral sphingomyelinase activation through the p55 receptor for tumor necrosis factor.
Adam-Klages S; Schwandner R; Adam D; Kreder D; Bernardo K; Krönke M
J Leukoc Biol; 1998 Jun; 63(6):678-82. PubMed ID: 9620659
[TBL] [Abstract][Full Text] [Related]
3. Identification of p55 tumor necrosis factor receptor-associated proteins that couple to signaling pathways not initiated by the death domain.
Adam D; Adam-Klages S; Krönke M
J Inflamm; 1995-1996; 47(1-2):61-6. PubMed ID: 8913930
[TBL] [Abstract][Full Text] [Related]
4. Interaction with factor associated with neutral sphingomyelinase activation, a WD motif-containing protein, identifies receptor for activated C-kinase 1 as a novel component of the signaling pathways of the p55 TNF receptor.
Tcherkasowa AE; Adam-Klages S; Kruse ML; Wiegmann K; Mathieu S; Kolanus W; Krönke M; Adam D
J Immunol; 2002 Nov; 169(9):5161-70. PubMed ID: 12391233
[TBL] [Abstract][Full Text] [Related]
5. FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase.
Adam-Klages S; Adam D; Wiegmann K; Struve S; Kolanus W; Schneider-Mergener J; Krönke M
Cell; 1996 Sep; 86(6):937-47. PubMed ID: 8808629
[TBL] [Abstract][Full Text] [Related]
6. Neutral sphingomyelinase: past, present and future.
Chatterjee S
Chem Phys Lipids; 1999 Nov; 102(1-2):79-96. PubMed ID: 11001563
[TBL] [Abstract][Full Text] [Related]
7. Requirement of FADD for tumor necrosis factor-induced activation of acid sphingomyelinase.
Wiegmann K; Schwandner R; Krut O; Yeh WC; Mak TW; Krönke M
J Biol Chem; 1999 Feb; 274(9):5267-70. PubMed ID: 10026132
[TBL] [Abstract][Full Text] [Related]
8. Roles for tumor necrosis factor receptor p55 and sphingomyelinase in repairing the cutaneous permeability barrier.
Jensen JM; Schütze S; Förl M; Krönke M; Proksch E
J Clin Invest; 1999 Dec; 104(12):1761-70. PubMed ID: 10606630
[TBL] [Abstract][Full Text] [Related]
9. TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase.
Schwandner R; Wiegmann K; Bernardo K; Kreder D; Kronke M
J Biol Chem; 1998 Mar; 273(10):5916-22. PubMed ID: 9488730
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor (TNF) interferes with insulin signaling through the p55 TNF receptor death domain.
Csehi SB; Mathieu S; Seifert U; Lange A; Zweyer M; Wernig A; Adam D
Biochem Biophys Res Commun; 2005 Apr; 329(1):397-405. PubMed ID: 15721320
[TBL] [Abstract][Full Text] [Related]
11. TNF-receptor I defective in internalization allows for cell death through activation of neutral sphingomyelinase.
Neumeyer J; Hallas C; Merkel O; Winoto-Morbach S; Jakob M; Thon L; Adam D; Schneider-Brachert W; Schütze S
Exp Cell Res; 2006 Jul; 312(11):2142-53. PubMed ID: 16631736
[TBL] [Abstract][Full Text] [Related]
12. A novel cytoplasmic domain of the p55 tumor necrosis factor receptor initiates the neutral sphingomyelinase pathway.
Adam D; Wiegmann K; Adam-Klages S; Ruff A; Krönke M
J Biol Chem; 1996 Jun; 271(24):14617-22. PubMed ID: 8663014
[TBL] [Abstract][Full Text] [Related]
13. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling.
Wiegmann K; Schütze S; Machleidt T; Witte D; Krönke M
Cell; 1994 Sep; 78(6):1005-15. PubMed ID: 7923351
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase.
Luberto C; Hassler DF; Signorelli P; Okamoto Y; Sawai H; Boros E; Hazen-Martin DJ; Obeid LM; Hannun YA; Smith GK
J Biol Chem; 2002 Oct; 277(43):41128-39. PubMed ID: 12154098
[TBL] [Abstract][Full Text] [Related]
15. Activation of ERK1/2 and cPLA(2) by the p55 TNF receptor occurs independently of FAN.
Lüschen S; Adam D; Ussat S; Kreder D; Schneider-Brachert W; Krönke M; Adam-Klages S
Biochem Biophys Res Commun; 2000 Aug; 274(2):506-12. PubMed ID: 10913368
[TBL] [Abstract][Full Text] [Related]
16. Neutral sphingomyelinase 2 (nSMase2) is the primary neutral sphingomyelinase isoform activated by tumour necrosis factor-α in MCF-7 cells.
Clarke CJ; Cloessner EA; Roddy PL; Hannun YA
Biochem J; 2011 Apr; 435(2):381-90. PubMed ID: 21303347
[TBL] [Abstract][Full Text] [Related]
17. Induction of stress-activated protein kinases/c-Jun N-terminal kinases by the p55 tumour necrosis factor receptor does not require sphingomyelinases.
Adam D; Ruff A; Strelow A; Wiegmann K; Krönke M
Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):343-50. PubMed ID: 9657974
[TBL] [Abstract][Full Text] [Related]
18. Role of nuclear factor-kappaB activation in cytokine- and sphingomyelinase-stimulated inducible nitric oxide synthase gene expression in vascular smooth muscle cells.
Katsuyama K; Shichiri M; Marumo F; Hirata Y
Endocrinology; 1998 Nov; 139(11):4506-12. PubMed ID: 9794459
[TBL] [Abstract][Full Text] [Related]
19. Neutral sphingomyelinase inhibition alleviates apoptosis, but not ER stress, in liver ischemia-reperfusion injury.
Tuzcu H; Unal B; Kırac E; Konuk E; Ozcan F; Elpek GO; Demir N; Aslan M
Free Radic Res; 2017 Mar; 51(3):253-268. PubMed ID: 28277984
[TBL] [Abstract][Full Text] [Related]
20. Fibrillar amyloid-beta-activated human astroglia kill primary human neurons via neutral sphingomyelinase: implications for Alzheimer's disease.
Jana A; Pahan K
J Neurosci; 2010 Sep; 30(38):12676-89. PubMed ID: 20861373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
